RELIQ HEALTH TECHNOLOGIES IN (RHT.CA) Stock Analyst Ratings
Canada - TSX Venture Exchange - TSX-V:RHT - CA75955T1030 - Common Stock
0.215 CAD
0 (0%)
ChartMill assigns a Buy % Consensus number of 84% to RHT.CA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 1.79. This target is 730.23% above the current price.
RHT.CA was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about RHT.CA.
In the previous month the buy percentage consensus was at a similar level.
RHT.CA was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
RELIQ HEALTH TECHNOLOGIES IN / RHT.CA FAQ
What do analysts expect the price target to be for RELIQ HEALTH TECHNOLOGIES IN (RHT.CA)?
9 analysts have analysed RHT.CA and the average price target is 1.79 CAD. This implies a price increase of 730.23% is expected in the next year compared to the current price of 0.215.
What is the consensus rating for RELIQ HEALTH TECHNOLOGIES IN (RHT.CA) stock?
The consensus rating for RELIQ HEALTH TECHNOLOGIES IN (RHT.CA) is 84.4444 / 100 . This indicates that analysts generally have a positive outlook on the stock.